Mandated enrollment into a high-deductible insurance plan delays the time it takes patients with diabetes to seek care for cardiovascular (macrovascular) disease-related symptoms, tests, and procedures, compared with those who remain on a low-deductible insurance plan, an observational, longitudinal study suggests.
“High-deductible plans, which require potential out-of-pocket spending of approximately $1000 to $7000 per person per year for most nonpreventive care, have become an increasingly common feature of US commercial health insurance,” Frank Wharam, MD, MPH, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, and colleagues observe in their article, published online November 19 in the Annals of Internal Medicine.
Read more at Medscape
Research Areas
You might also be interested in...
View all News-
Preventive care is under threat: PrEP now or pay later
July 20, 2024 -
Colorectal Cancer Screening: How to Increase Rates
June 10, 2024 -
Dr Ravi Parikh Presents Groundbreaking BE-a-PAL Data on Default Palliative Care Referrals
June 2, 2024 -
To Boost Colon Cancer Screening, Give Patients Choices
May 21, 2024 -
Dr. Kim Waddell on Changing Behaviors to Improve Long-Term Health Outcomes in Adults With Neurologic Disease
May 20, 2024 -
Offering Both Colonoscopy and At-Home Tests Doubled Colorectal Cancer Screening
May 16, 2024 -
Patients Hate ‘Forever’ Drugs. Is Wegovy Different?
March 24, 2024 -
Penn Medicine News: Penn Medicine Researchers Awarded $27.5 Million for Large Palliative Care Study
July 19, 2023 -
Being Patient: Dr. Emily Largent: Making Clinical Trials Better for Participants
March 7, 2023 -
CNN: Opinion: My Near-Death Experience Teaches a Lesson
January 26, 2023 -
ACP Hospitalist: Hospitalists Can Help Eliminate HCV
January 12, 2023 -
FOX29 Philadelphia: Local Doctor Details Cardiac Arrest, Predicts Recovery Process for Damar Hamlin
January 3, 2023